Liver cancer is diagnosed using a combination of blood tests, imaging studies, and sometimes a biopsy. Blood tests can reveal elevated liver enzymes like GGT, which may indicate liver damage or disease. Bilirubin levels, especially direct bilirubin, can rise when the liver cannot process waste properly. Tumor markers like CA 19-9 may be elevated in some liver cancers and help assess the extent of disease. Testing for hepatitis C antibodies helps identify chronic infection, a major risk factor for liver cancer.
Rite Aid offers blood testing that includes key liver health markers like bilirubin, GGT, CA 19-9, and hepatitis C antibody screening. These tests can detect early warning signs and help monitor your liver health over time. If blood tests show concerning results, your doctor will likely order imaging tests like ultrasound, CT scan, or MRI to look at your liver directly. A liver biopsy may be needed to confirm cancer and determine its type.